NCT05704933 2025-10-20Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain MetastasesH. Lee Moffitt Cancer Center and Research InstitutePhase EARLY_PHASE1 Completed1 enrolled